Medicus Sciencescquisition Corp. Class A (MSAC) Financials
$10.17
$0.00 (0.00%)As on 24-Feb-2023 09:30EDT
Market cap
$118 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
31.8
P/B Ratio
1.3
Div. Yield
0 %
Cashflow ($ Mln) |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-0.80
|
-0.80
|
--
|
--
|
--
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-92.00
|
-92.00
|
--
|
--
|
--
|
|||||
|
Cash from Financing Activities
|
--
|
94.23
|
0.02
|
--
|
--
|
--
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
Financials Ratios |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
1,126,290.34
|
0.95
|
--
|
--
|
--
|
--
|
|||||
|
Cash EPS ($)
|
--
|
0.95
|
--
|
--
|
--
|
--
|
|||||
|
Adjusted Book Value ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
-0.40
|
--
|
--
|
--
|
--
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
-0.40
|
--
|
--
|
--
|
--
|
Profitability Ratios |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
3,930.41
|
--
|
--
|
--
|
--
|
|||||
|
ROE (%)
|
--
|
30,887.41
|
--
|
--
|
--
|
--
|
|||||
|
ROA (%)
|
2,404,266.06
|
1,703.58
|
--
|
--
|
--
|
--
|
|||||
|
EBIT Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Net Margin (%)
|
47,290,963.85
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EBIT Growth (%)
|
--
|
-744.15
|
--
|
--
|
--
|
--
|
|||||
|
Net Profit Growth (%)
|
--
|
31,366.51
|
--
|
--
|
--
|
--
|
|||||
|
EPS Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Book Value Growth (%)
|
-103.30
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
31.78
|
10.24
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
1.30
|
-2,926.39
|
--
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
-165.43
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Close Price ($)
|
9.90
|
9.72
|
--
|
--
|
--
|
--
|
|||||
|
High Price ($)
|
9.92
|
10.50
|
--
|
--
|
--
|
--
|
|||||
|
Low Price ($)
|
9.66
|
9.58
|
--
|
--
|
--
|
--
|
|||||
|
Market Cap ($ Cr)
|
118.12
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
--
|
4.45
|
--
|
--
|
--
|
|||||
|
Short term debt to equity ratio
|
--
|
--
|
4.45
|
--
|
--
|
--
|
|||||
|
Current Ratio
|
18.86
|
0.05
|
1.17
|
--
|
--
|
--
|
|||||
|
Quick Ratio
|
18.86
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Interest Coverage
|
--
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency Ratios |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Asset Turnover
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Receivable days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Inventory Days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Payable days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
--
|
--
|
--
|
--
|